Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
Current Opinion in Pharmacology
|
January 3, 2014
The proton-coupled folate transporter: physiological and pharmacological roles
Rongbao Zhao, I David Goldman
Cancer Metastasis Reviews
|
March 7, 2007
The molecular identity and characterization of a Proton-coupled Folate Transporter--PCFT; biological ramifications and impact on the activity of pemetrexed
Rongbao Zhao, I David Goldman
Molecular Aspects of Medicine
|
March 20, 2013
Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors
Rongbao Zhao, I David Goldman
Oncogene
|
October 25, 2003
Resistance to antifolates
Rongbao Zhao, I David Goldman
Seminars in Oncology
|
February 7, 2003
Molecular, biochemical, and cellular pharmacology of pemetrexed
I David Goldman, Rongbao Zhao
The Oncologist
|
June 1, 2004
Enter Alimta: a new generation antifolate
Rongbao Zhao, I David Goldman
Molecular Pharmacology
|
May 5, 2012
Augmentation of reduced folate carrier-mediated folate/antifolate transport through an antiport mechanism with 5-aminoimidazole-4-carboxamide riboside monophosphate
Michele Visentin, Rongbao Zhao, I David Goldman
Hematology/Oncology Clinics of North America
|
April 24, 2012
The antifolates
Michele Visentin, Rongbao Zhao, I David Goldman
Molecular Aspects of Medicine
|
September 25, 2016
The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption
Rongbao Zhao, Srinivas Aluri, I David Goldman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2004
Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier
Yanhua Wang, Rongbao Zhao, I David Goldman
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
Current Opinion in Pharmacology
|
January 3, 2014
The proton-coupled folate transporter: physiological and pharmacological roles
Rongbao Zhao, I David Goldman
Cancer Metastasis Reviews
|
March 7, 2007
The molecular identity and characterization of a Proton-coupled Folate Transporter--PCFT; biological ramifications and impact on the activity of pemetrexed
Rongbao Zhao, I David Goldman
Molecular Aspects of Medicine
|
March 20, 2013
Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors
Rongbao Zhao, I David Goldman
Oncogene
|
October 25, 2003
Resistance to antifolates
Rongbao Zhao, I David Goldman
Seminars in Oncology
|
February 7, 2003
Molecular, biochemical, and cellular pharmacology of pemetrexed
I David Goldman, Rongbao Zhao
The Oncologist
|
June 1, 2004
Enter Alimta: a new generation antifolate
Rongbao Zhao, I David Goldman
Molecular Pharmacology
|
May 5, 2012
Augmentation of reduced folate carrier-mediated folate/antifolate transport through an antiport mechanism with 5-aminoimidazole-4-carboxamide riboside monophosphate
Michele Visentin, Rongbao Zhao, I David Goldman
Hematology/Oncology Clinics of North America
|
April 24, 2012
The antifolates
Michele Visentin, Rongbao Zhao, I David Goldman
Molecular Aspects of Medicine
|
September 25, 2016
The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption
Rongbao Zhao, Srinivas Aluri, I David Goldman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2004
Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier
Yanhua Wang, Rongbao Zhao, I David Goldman
Page
of 7